secwatch / observer
8-K filed May 27, 2026, 4:01 PM ET ticker SNBR CIK 0000827187
other material confidence high sentiment neutral materiality 0.40

Sleep Number holders approve equity plan increase; board declassification proposals fail

Sleep Number Corp

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0000827187-26-000045
form_type
8-K
ticker
SNBR
cik
0000827187
company_name
Sleep Number Corp
filed_at
2026-05-27T20:01:22+00:00
discovered_at
2026-05-27T20:02:00.304428+00:00
generated_at
2026-05-27T20:03:37.529436+00:00
sec_items
["5.02", "5.07", "8.01", "9.01"]
event_type
other_material
sentiment
neutral
materiality_score
0.4
calibrated_materiality_score
0.4
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0000827187-26-000045
json_url
https://secwatch.observer/filing/0000827187-26-000045.json
markdown_url
https://secwatch.observer/filing/0000827187-26-000045.md
text_url
https://secwatch.observer/filing/0000827187-26-000045.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/827187/000082718726000045/0000827187-26-000045-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/827187/000082718726000045/snbr-20260521.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null

Comparable filings

RDAC

Shareholders approve SPAC extension to Oct 15, 2027; ~1.9M shares redeemed

Rising Dragon Acquisition Corp. June 1, 2026, 6:08 AM ET other_material Items 1.01, 5.03, 5.07, 8.01, 9.01

same SEC item: 5.07, 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

TNYA

Tenaya shareholders approve amended equity plan adding 6.5M shares, elect directors

Tenaya Therapeutics, Inc. May 29, 2026, 5:04 PM ET other_material Items 5.02, 5.07, 9.01

same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

SYRE

Spyre Therapeutics stockholders approve amended ESPP; director Peter Harwin resigns

Spyre Therapeutics, Inc. May 29, 2026, 4:45 PM ET other_material Items 5.02, 5.07, 9.01

same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

EVC

Entravision stockholders approve 6M share increase in equity plan at annual meeting

ENTRAVISION COMMUNICATIONS CORP May 29, 2026, 4:30 PM ET other_material Items 5.02, 5.07, 9.01

same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

EFC

Ellington Financial stockholders approve 2026 Equity Incentive Plan and reelect directors

Ellington Financial Inc. May 29, 2026, 4:13 PM ET other_material Items 5.02, 5.07, 9.01

same SEC item: 5.02, 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

ONCY

Oncolytics reports positive initial preclinical data for pelareorep + RAS inhibitors; further studies planned

ONCOLYTICS BIOTECH INC June 1, 2026, 9:06 AM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

NWSA

News Corp repurchased $2.75M in shares on May 29; $276.9M used under $1B program

NEWS CORP June 1, 2026, 6:32 AM ET other_material Items 8.01, 9.01

same SEC item: 8.01, 9.01 same event type: other_material similar materiality

Filing page SEC filing

AVX

Avax One shareholders approve reverse stock split (1:2 to 1:12) at annual meeting

AVAX ONE TECHNOLOGY LTD. May 29, 2026, 4:30 PM ET other_material Items 5.07, 9.01

same SEC item: 5.07, 9.01 same event type: other_material similar materiality

Filing page SEC filing

Source: SEC EDGAR
accession 0000827187-26-000045

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.